An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

Flebogamma DIF 5% & 10%

STN: 125077
Proper Name: Immune Globulin Intravenous (Human)
Tradename: Flebogamma DIF 5% & 10 %
Manufacturer: Instituto Grifols, SA, License #1181
Indication:

Flebogamma 5% DIF: Treatment of primary (inherited) immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
Flebogamma 10% DIF: Treatment of (1) primary (inherited) immunodeficiency; (2) chronic primary immune thrombocytopenia (ITP) in patients 2 years of age and older.

Product Information

Supporting Documents

Supporting Documents older than three years - Flebogamma DIF 5% and 10%

Top